Use of quinolones in pediatrics
- 1 April 1991
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 10 (4) , 355-360
- https://doi.org/10.1007/bf01967011
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Quinolone antimicrobial agents: Adverse effects and bacterial resistanceEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Value of new quinolones in the treatment and prophylaxis of infectious diseases: Introductory remarksEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Clinical role of the quinolones today and in the futureEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Antipseudomonal therapy in cystic fibrosis: Aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Extended AbstractsClinical Infectious Diseases, 1989
- Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 1987
- CIPROFLOXACIN FOR CHOLANGITIS AFTER HEPATIC PORTOENTEROSTOMYThe Lancet, 1987
- Ofloxacin in Cystic FibrosisDrugs, 1987
- Use of ciprofloxacin in the treatment ofPseudomonas aeruginosa infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- In vitro Activity of Ciprofloxacin against Pediatric PathogensChemotherapy, 1985